Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs starting with two of Takeda’s ...
In this workshop, we’ll explore the process of relighting a 3D environment in Unreal Engine, taking inspiration from Luminism and the Hudson River School. Rather than aiming for strict realism, this ...
The Building Management System (BMS system) and the practice of building automation in the age of IP, IoT (Internet of Things), big data, advanced analytics and hyper-connectivity. An intelligent and ...
Smart BMS is an Open Source Battery Management System for Lithium Cells (Lifepo4, Li-ion, NCM, etc.) Battery Pack. The voltage and the temperature values of each cell are acquired by the relevant Cell ...
Abstract: Electric-drive vehicles require a battery management system (BMS) for normal, safe operation of the battery pack, and a DC/DC converter to supply auxiliary loads on the low-voltage (LV) DC ...
Abstract: Being able to build a map of the environment and to simultaneously localize within this map is an essential skill for mobile robots navigating in unknown environments in absence of external ...
Chemical Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States ...
Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing Tech University (Nanjing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results